Daniel Gesua Sive Salvadori is President & VP at ABBOTT LABORATORIES (ABT). They have made 23 open-market trades across 1 company since 2015, most recently 2026-03-02.
CIK 0001620564
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 23 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABT | 146,377 | $16.9M |
Shares reported on the most recent Form 4, priced at the 2026-03-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABT | SELL | 2026-03-02 | 2026-03-03 | $115.58 | $102K | -4.9% | -9.5% | -22.8% |
| ABT | SELL | 2025-01-30 | 2025-01-31 | $128.50 | $6.1M | +3.0% | +10.7% | +3.3% |
| ABT | SELL | 2024-03-01 | 2024-03-04 | $118.50 | $228K | -1.3% | -7.6% | -14.6% |
| ABT | SELL | 2023-03-01 | 2023-03-02 | $100.70 | $219K | -4.2% | -1.3% | -0.9% |
| ABT | SELL | 2022-03-01 | 2022-03-02 | $118.17 | $366K | -4.4% | -1.8% | -2.8% |
| ABT | SELL | 2021-12-23 | 2021-12-28 | $140.00 | $8.2M | -3.5% | -14.3% | -14.6% |
| ABT | SELL | 2021-12-13 | 2021-12-15 | $135.00 | $7.9M | +3.7% | -5.4% | -13.3% |
| ABT | SELL | 2021-03-01 | 2021-03-02 | $120.61 | $401K | -4.1% | -2.3% | -13.1% |
| ABT | SELL | 2020-08-27 | 2020-08-31 | $111.86 | $9.5M | -3.9% | -0.1% | -0.7% |
| ABT | SELL | 2020-03-02 | 2020-03-03 | $77.89 | $156K | +1.2% | -1.5% | +15.3% |
| ABT | SELL | 2019-06-26 | 2019-06-27 | $84.00 | $6.0M | +1.7% | +5.5% | -1.3% |
| ABT | SELL | 2019-06-11 | 2019-06-13 | $82.00 | $869K | +2.5% | +2.0% | +2.9% |
| ABT | SELL | 2019-03-01 | 2019-03-04 | $78.00 | $130K | +0.5% | +1.2% | -3.6% |
| ABT | SELL | 2018-09-28 | 2018-10-02 | $73.39 | $367K | -6.1% | -5.0% | -2.0% |
| ABT | SELL | 2018-05-17 | 2018-05-21 | $61.20 | $184K | +0.5% | +0.1% | +4.1% |
| ABT | SELL | 2018-03-01 | 2018-03-02 | $58.97 | $107K | +6.7% | -1.2% | +4.4% |
| ABT | SELL | 2017-12-14 | 2017-12-14 | $54.92 | $1.4M | +4.4% | +6.2% | +14.2% |
| ABT | SELL | 2017-12-14 | 2017-12-14 | $54.92 | $1.6M | +4.4% | +6.2% | +14.2% |
| ABT | SELL | 2017-11-14 | 2017-11-16 | $55.00 | $3.9M | +0.4% | +1.9% | +5.3% |
| ABT | SELL | 2017-10-23 | 2017-10-25 | $56.21 | $10.9M | -0.6% | +1.4% | +7.0% |
| ABT | SELL | 2017-09-26 | 2017-09-28 | $52.95 | $3.3M | +3.3% | +1.2% | +7.1% |
| ABT | SELL | 2017-03-01 | 2017-03-02 | $45.39 | $188K | -1.4% | -2.1% | +0.5% |
| ABT | SELL · 10b5-1 | 2016-09-26 | 2016-09-28 | $41.71 | $34K | +3.3% | -6.1% | -8.3% |
| ABT | SELL | 2016-02-29 | 2016-03-02 | $39.26 | $35K | +5.0% | +9.4% | +2.8% |
| ABT | SELL · 10b5-1 | 2015-09-28 | 2015-09-29 | $39.65 | $32K | -8.3% | -2.3% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.